Literature DB >> 17057945

Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.

Sharon Hassin-Baer1, Yair Levy, Pnina Langevitz, Sasson Nakar, Michael Ehrenfeld.   

Abstract

The nervous system may be involved in up to 30% of patients with Sjogren's syndrome (SS). We describe three patients with Sjogren's syndrome and a concomitant parkinsonian syndrome. Elevated titers of anti-beta2-glycoprotein I IgG were found in the serum of all three patients. This autoantibody is strongly associated with anticardiolipin (aCL) antibodies, antiphospholipid syndrome (APS), and thromboembolic phenomena, but its role in the pathogenesis of the parkinsonian disorder in SS is unclear. These patients may present a subtype of SS patients in which the presence of aCL antibodies is associated with central nervous system involvement predominantly in the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057945     DOI: 10.1007/s10067-006-0398-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

Review 1.  Cholinergic-drug induced sicca syndrome in Parkinson's disease: a case report and a review of the literature.

Authors:  S Hashimoto; T Sawada; T Inoue; K Yamamoto; M Iwata
Journal:  Clin Neurol Neurosurg       Date:  1999-12       Impact factor: 1.876

Review 2.  Central nervous system disease in Sjögren's syndrome. New insights into immunopathogenesis.

Authors:  E Alexander
Journal:  Rheum Dis Clin North Am       Date:  1992-08       Impact factor: 2.670

3.  Serial measurements of anticardiolipin antibodies in primary Sjögren's syndrome.

Authors:  Y L Pennec; G Magadur; J Jouquan; P Youinou
Journal:  Clin Exp Rheumatol       Date:  1991 Mar-Apr       Impact factor: 4.473

4.  Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study.

Authors:  G E Tietjen; M Day; L Norris; S Aurora; A Halvorsen; L R Schultz; S R Levine
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

5.  Lack of association between antiphospholipid antibodies and migraine in children.

Authors:  A Verrotti; F Cieri; P Pelliccia; G Morgese; F Chiarelli
Journal:  Int J Clin Lab Res       Date:  2000

6.  The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.

Authors:  P A Merkel; Y Chang; S S Pierangeli; K Convery; E N Harris; R P Polisson
Journal:  Am J Med       Date:  1996-12       Impact factor: 4.965

7.  Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  M Inanç; S Donohoe; C T Ravirajan; E L Radway-Bright; I Mackie; S Machin; D A Isenberg
Journal:  Br J Rheumatol       Date:  1998-10

8.  Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells.

Authors:  B Caronti; C Calderaro; C Alessandri; F Conti; R Tinghino; C Pini; G Palladini; G Valesini
Journal:  J Autoimmun       Date:  1998-10       Impact factor: 7.094

9.  Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer.

Authors:  Y Shoenfeld; A Nahum; A D Korczyn; M Dano; R Rabinowitz; O Beilin; C G Pick; L Leider-Trejo; L Kalashnikova; M Blank; J Chapman
Journal:  Lupus       Date:  2003       Impact factor: 2.911

10.  Parkinsonian syndrome complicating systemic lupus erythematosus.

Authors:  E Shahar; E Goshen; Z Tauber; E Lahat
Journal:  Pediatr Neurol       Date:  1998-05       Impact factor: 3.372

View more
  4 in total

1.  Neuromelanin is an immune stimulator for dendritic cells in vitro.

Authors:  Uwe Oberländer; Katrien Pletinckx; Anja Döhler; Nora Müller; Manfred B Lutz; Thomas Arzberger; Peter Riederer; Manfred Gerlach; Eleni Koutsilieri; Carsten Scheller
Journal:  BMC Neurosci       Date:  2011-11-15       Impact factor: 3.288

2.  Parkinsonism and Sjögren's Syndrome: A Fortuitous Association or a Shared Immunopathogenesis?

Authors:  Mariem Kchaou; Nadia Ben Ali; Intissar Hmida; Saloua Fray; Hela Jamoussi; Mohamed Jalleli; Slim Echebbi; Afef Achouri; Samir Belal
Journal:  Case Rep Med       Date:  2015-05-31

Review 3.  Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature.

Authors:  Rikitha Menezes; Alexander Pantelyat; Izlem Izbudak; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

4.  Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.

Authors:  Ming-Chi Wu; Xun Xu; Shan-Ming Chen; Yeu-Sheng Tyan; Jeng-Yuan Chiou; Yu-Hsun Wang; Li-Chi Lin; Chyong-Mei Chen; James Cheng-Chung Wei
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.